Chemotherapeutic reagents 5-Fluorouracil, Oxaliplatin and Irinotecan had been purchased from Sigma-Aldrich (Hamburg, Germany)
In our study we aimed at investigating mobile dying induction, proliferation, migration and invasion of CRC cells after deletion of Bcl-two, Bcl-xL or Mcl-1 expression. Importantly, a knockdown of antiapoptotic…